Live Breaking News & Updates on Drug Eluting Stent|Page 4

Stay updated with breaking news from Drug eluting stent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Parity for OCT, IVUS in Intravascular Imaging-Guided PCI

The two types of imaging catheter, as guides for coronary stent targeting and deployment, led to similar clinical outcomes in the OCTIVUS trial. A meta-analysis backed it up. ....

New York , United States , South Korea , Soult Ukpyolsi , Noord Holland , Davide Capodanno , Chong Kun Dang Pharma , Daewoong Pharma , Biosense Webster , Deepakl Bhatt , Elucid Bio , Mount Sinai Heart Health System , University Of Catania , Asan Medical Center , Cardiovascular Research Foundation , European Society Of Cardiology , Ablative Solutions , University Of Ulsan College Medicine , Icahn School Of Medicine , Boehringer Ingelheim , Duk Woo Park , European Society , Ulsan College , Gregg Stone , New York City , Medscape Cardiology ,

Mortality Rates Falling After PCI for STEMI

In Denmark, 1-year mortality after percutaneous coronary intervention for STEMI was reduced by about 30% from 2003 to 2018; most of the reduction was seen within the first 30 days after the procedure. ....

United States , Timothyd Henry , Aarhus University Hospital , Journal Of The American College Cardiology , Christ Hospital Health Network , Ejnar Danielsen Foundation , Lindner Center , Department Of Cardiology , Pernille Gro Thrane , American College , Ejnar Danielsen , Myocardial Infarction , Percutaneous Coronary Intervention , United Kingdom Site Content , Clinical Guidelines , Drug Eluting Stent , T Segment Elevation Mi , St Segment Elevation Myocardial Infarction , Cardiac Arrest ,

Aspirin Still Needed in First Month After PCI: STOPDAPT-3

Using prasugrel (Effient) alone in the first month after PCI did not reduce bleeding risk and there was a suggestion of possible increased ischemic risk vs dual antiplatelet therapy, in a new trial. ....

Noord Holland , Marco Valgimigli , Masahiro Natsuaki , European Society Of Cardiology , Cardiocentro Ticino Foundation , Saga University , European Society , Erebrovascular Accident , Va Cerebrovascular Accident , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Antiplatelet Agent , Neuroendocrine Tumor , Drug Eluting Stent , Myocardial Infarction , Percutaneous Coronary Intervention ,

Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for cardiovascular events in patients with acute coronary syndrome (ACS) or high bleeding risk (HBR), according to late breaking research presented in a Hot Line session today at ESC Congress 2023. ....

Megan Craig , Masahiro Natsuaki , Academic Research Consortium , Saga University , Hot Line , Bleeding Academic Research Consortium , Study Author , Cute Coronary Syndrome , Drug Eluting Stent , Myocardial Infarction ,

Drug Device Combination Products Market Size & Share

The Drug Device Combination Products Market size is expected to grow from USD 125.70 billion in 2023 to USD 166.63 billion by 2028, at a CAGR of 5.80%. ....

United States , New York , Breyna Budesonide , Astrazeneca Symbicort , Boston Scientific Corp , Antares Pharma Inc , Assertio Holdings Inc , Abbott Laboratories , Viatris Inc , National University Of Ireland Galway , University Hospital Galway , Medtronic Plc , Drug Administration , Device Combination Products Market Size , Share Analysis , Drug Device Combination Products Market , Safe Plus , Eluting Stents , Notable Rates Over , National University , Ireland Galway , Drug Eluting Stent , Onyx Frontier , Have Significant Market Share , United States Food , Abbreviated New Drug Application ,